Table 5 Comparison between body weight, serum glucose level, lipid profile, liver and kidney functions in males versus female obese groups without ZnSO₄ tretatment, low dose (15 mg) ZnSO₄ treatment, and high dose (30 mg) ZnSO₄ treatment.

Body weight (g)

419 ± 8.2^a

324.3 ± 42.7

303.9 ± 20.4

331.4 ± 16.3^b

189.1 ± 7.2^de

178.3 ± 30.5^e

Glucose (mg/dl)

130.3 ± 3.5^a

94.2 ± 6.6^bcd

96.7 ± 9.8^bc

132.2 ± 11.0^a

105.0 ± 9.8^b

95.8 ± 5.2^bc

Lipid profile

 Lipids (mg/dl)

406.5 ± 22.6^a

355.7 ± 14.4^b

343.3 ± 16..2^bc

307.2 ± 18.4^cd

283.2 ± 36.3^de

281.7 ± 40.5^de

 Cholesterol (mg/dl)

129.0 ± 10.3^a

111.0 ± 28.0^ab

112.3 ± 13.6^ab

102.6 ± 8.4^bc

81.2 ± 9.1^cd

82.7 ± 25.6^cd

 Triglyceride (mg/dl)

196.3 ± 17.3^a

157.3 ± 7.4^b

153.3 ± 12.0^b

218.7 ± 27.8^a

153.7 ± 20.3^b

160.2 ± 6.9^b

Liver enzymes

 GOT (U/L)

275.0 ± 57.1^a

199.2 ± 27.7^b

173.0 ± 10.7^bc

154.8 ± 15.8^cde

133.1 ± 15.6^def

128.8 ± 21.2^ef

 GPT (U/L)

93.1 ± 5.0^a

40.9 ± 5.4^ef

41.1 ± 5.8^def

51.6 ± 7.9^c

35.92 ± 4.4 ^fg

35.6 ± 3.3 ^fg

Kidney functions

 Urea (mg/dl)

42.2 ± 2.6^a

38.3 ± 1.9^abcd

38.4 ± 2.1^abc

41.1 ± 4.5^a

36.2 ± 3.6^cde

36.9 ± 3.1^cde

 Uric acid (mg/dl)

2.6 ± 0.4^e

3.3 ± 0.6^cde

3.4 ± 0.2^cd

4.5 ± 1.3^bs

3.7 ± 0.4^cd

3.7 ± 0.5^cd

 Creatinine (mg/dl)

0.6 ± 0.05^ab

0.6 ± 0.07^ab

0.6 ± 0.08^ab

0.5 ± 0.08^b

0.6 ± 0.08^ab

0.5 ± 0.07^b